Wadi N. Suki, MD

Professor of Medicine, Institute for Academic Medicine
Program Director, Nephrology Residency, Department of Medicine
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Suki is the Program Director of Houston Methodist Hospital's Nephrology Fellowship Program. He received his medical degree from the American University of Beirut School of Medicine, and completed his post-doctoral training in Internal Medicine, and Hypertension and Nephrology at the University of Texas Southwestern Medical School and Parkland Memorial Hospital in Dallas, Texas. Dr. Suki has served as a consultant to and member of the Board of Directors of a number of governmental agencies, voluntary health organizations and professional organizations. He has also served and continues to serve on the editorial boards of numerous scientific journals. Dr. Suki has written more than 250 scientific publications addressing many aspects of renal physiology and disease, including hypertension and diabetes. His contributions have been recognized by such awards as the President's Medal of the American Society of Nephrology, 1991, The David M. Hume Award of the National Kidney Foundation, 1994, and President of the American Society of Nephrology, 1997-1998.

Publications

Change in QTC Interval After Kidney Transplant
Lai, E, Acharya, V, Nguyen, DTM, Graviss, EA & Suki, WN 2017, 2017 American Transplant Congress, 4/30/17, .

Comparison of the Estimated and Measured Glomerular Filtration Rate in Kidney Donor Candidates
Akhimiona, C, Suki, W, Nguyen, D & Graviss, E 2017, . in Am J Transplant. vol. 17, pp. 789-790, 2017 American Transplant Congress, 30 April.

Outcomes of Kidney Transplantation Using Deceased Diabetic Donors
Khan, KMF, Suki, WN, Nguyen, DTM & Graviss, EA 2017, 2017 American Transplant Congress, 4/30/17, .

Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study
Rossitter, CW, Vigo, RB, Gaber, AO, Swan, JT & Suki, WN 2017, Transplantation Direct, vol 3, no. 3, pp. e135. DOI: 10.1097/TXD.0000000000000649

Phosphorus Regulation in Chronic Kidney Disease
Suki, WN & Moore, LW 2016, Methodist DeBakey cardiovascular journal, vol 12, no. 4, pp. 6-9. DOI: 10.14797/mdcj-12-4s1-6

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol 29, no. 8, pp. 897-908. DOI: 10.1111/tri.12791

Association of dietary phosphate and serum phosphorus concentration by levels of kidney function
Moore, LW, Nolte, JV, Gaber, AO & Suki, WN 2015, American Journal of Clinical Nutrition, vol 102, no. 2, pp. 444-453. DOI: 10.3945/ajcn.114.102715

Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease
Weinman, EJ, Light, PD & Suki, WN 2013, American Journal of Kidney Diseases, vol 62, no. 5, pp. 1006-1011. DOI: 10.1053/j.ajkd.2013.04.013

Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery
Gaber, AO , Moore, LW, Aloia, TA, Suki, WN, Jones, SL, Graviss, EA, Knight, RJ & Bass, BL 2013, Annals of Surgery, vol 258, no. 1, pp. 169-177. DOI: 10.1097/SLA.0b013e318288e18e

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
Devos, JM, Gaber, AO, Knight, RJ, Land, GA, Suki, WN, Gaber, LW & Patel, SJ 2012, Kidney International, vol 82, no. 5, pp. 598-604. DOI: 10.1038/ki.2012.190

Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy
Soltero, L, Carbajal, H, Xu, J, Mccarthy, J, Suki, WN, Gaber, AO & Adrogué, HE 2012, Clinical Transplantation, vol 26, no. 2, pp. 300-304. DOI: 10.1111/j.1399-0012.2011.01539.x

Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60yr of age
Patel, SJ, Knight, RJ, Suki, WN, Abdellatif, A, Duhart, BT, Krauss, AG, Mannan, S, Nezakatgoo, N & Osama Gaber, A 2011, Clinical Transplantation, vol 25, no. 3. DOI: 10.1111/j.1399-0012.2010.01393.x

Introduction of New Technologies for the Treatment of Diabetic Complications: Cryoreactive Albumin Removal Apheresis
Nosé, Y, Ohta, K, Suki, WN, Takaba, J & Miyamoto, H 2011, Artificial Organs, vol 35, no. 1, pp. 4-8. DOI: 10.1111/j.1525-1594.2010.01178.x

Cardioprotective medication use after renal transplantation
Dawson, KL, Patel, SJ, Putney, D, Suki, WN & Osama Gaber, A 2010, Clinical Transplantation, vol 24, no. 6. DOI: 10.1111/j.1399-0012.2010.01297.x

Pulmonary alveolar proteinosis in a kidney transplant: A rare complication of sirolimus
Kadikoy, H, Paolini, M, Achkar, K, Suki, W, Gaber, AO, Anwar, N, Jeroudi, A, Barrios, R & Abdellatif, A 2010, Nephrology Dialysis Transplantation, vol 25, no. 8, pp. 2795-2798. DOI: 10.1093/ndt/gfq265

A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis
Fishbane, S, Delmez, J, Suki, WN, Hariachar, SK, Heaton, J, Chasan-Taber, S, Plone, MA & Moe, S 2010, American Journal of Kidney Diseases, vol 55, no. 2, pp. 307-315. DOI: 10.1053/j.ajkd.2009.10.051

Bortezomib in kidney transplant desensitization: a case report.
Raghavan, R, Jeroudi, A, Achkar, K, Suki, W, Gaber, AO, Knight, R, Land, G, Dilioglou, S, Patel, S & Abdellatif, A 2009, Clinical transplants, pp. 339-342.

Response to 'Lack of mortality benefit with sevelamer'
Suki, WN 2008, Kidney International, vol 73, no. 9, pp. 1093-1094. DOI: 10.1038/ki.2008.47

Effects of Sevelamer and Calcium-Based Phosphate Binders on Mortality in Hemodialysis Patients: Results of a Randomized Clinical Trial
Suki, WN 2008, Journal of Renal Nutrition, vol 18, no. 1, pp. 91-98. DOI: 10.1053/j.jrn.2007.10.019

Early-onset rhabdomyolysis related to daptomycin use
Patel, SJ, Samo, TC & Suki, WN 2007, International Journal of Antimicrobial Agents, vol 30, no. 5, pp. 472-474. DOI: 10.1016/j.ijantimicag.2007.07.009